Trial 26866138MMY3013

Trial Trial design Status In-/Exclusion Therapy Participants Documents Permissions Tumorboards

Trial

Trial acronym

26866138MMY3013

Full title

Bortezomib in der Konsolidierungstherapie bei Patienten im Alter von 61-75 Jahren mit Multiplem Myelom

EudraCT number

2005-004947-73

NCT number

NCT00416208

Responsible organization

Medizinische Klinik III, Telefon: 089440072551

Classification	Code	Description
ICD-10-GM	C90.0-	Multiples Myelom
-		Bloodcancer (leukemia, lymphoma)

Trial type

Interventional

Blinding type

Open

Phase

III

Status

Recruitment finished

Votes

Institutional review board - vote

Unknown

Initiiation & lock

Date of lock (planned / actual)

2013-05-31 / Unknown

	Function	Prename	Surname	Organization
	Principal Investigator	MICHAEL	UNTERHALT	Keine Organisationseinheit angegeben